PMID: 2116166May 29, 1990Paper

Effect of phosphatidylethanolamine on the properties of phospholipid-apolipoprotein complexes

Biochemistry
E A Bonomo, J B Swaney

Abstract

Plasma high density lipoproteins (HDL) are synthesized in intestinal mucosal cells and hepatocytes and are secreted into the blood. Factors influencing the structure and function of these HDL, such as lipid and protein composition, are poorly understood. It appears, however, that intracellular, discoidal HDL are enriched, relative to plasma HDL, in phosphatidylethanolamine (PE), a phospholipid known to generate unusual, nonbilayer structures of putative physiological significance. Although incubation of dimyristoylphosphatidylcholine (DMPC) with apolipoprotein A-I at the gel-liquid crystalline phase transition temperature results in the spontaneous formation of lipid-protein complexes, the presence of proportionately small amounts of PE prevents the formation of such complexes, suggesting that PE profoundly alters the phase properties of the phospholipid bilayers. However, by using a detergent-mediated method for the formation of PE-rich model nascent HDL from phospholipids and apolipoprotein A-I, lipid-protein complexes containing as much as 75% DLPE could be formed, thus demonstrating that the presence of PE causes a kinetic, rather than a thermodynamic, barrier to spontaneous complex formation. The products contained a DLPE:...Continue Reading

References

Sep 1, 1976·The Journal of Clinical Investigation·R L HamiltonR J Havel
Jul 22, 1977·Biochimica Et Biophysica Acta·D W AndersonF T Lindgren
Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·S Mabrey, J M Sturtevant
Jan 1, 1986·Methods in Enzymology·T M Forte, R W Nordhausen
May 1, 1988·Scandinavian Journal of Clinical and Laboratory Investigation·G HedenborgA Ritzén
Jan 1, 1986·Methods in Enzymology·V N Schumaker, D L Puppione
Jan 1, 1986·Methods in Enzymology·J L Kelley, A W Kruski
Apr 15, 1986·Biochimica Et Biophysica Acta·H M LabodaM C Phillips
Apr 23, 1974·Biochemical and Biophysical Research Communications·R B Verdery, A V Nichols
Jan 1, 1983·Annual Review of Physiology·C L Bisgaier, R M Glickman
Mar 27, 1984·Biochimica Et Biophysica Acta·B Landin, A Nilsson
Nov 25, 1980·Biochemistry·J B Swaney, B C Chang
Mar 9, 1983·Biochimica Et Biophysica Acta·H H MantschD G Cameron
Mar 1, 1982·The Journal of Cell Biology·K E Howell, G E Palade
Sep 24, 1981·Biochimica Et Biophysica Acta·P J BlancheA V Nichols
Jan 1, 1959·Biochimica Et Biophysica Acta·G V MARINETTIE STOTZ

❮ Previous
Next ❯

Citations

Apr 29, 2010·Current Diabetes Reports·Andrew N HoofnagleAlan Chait
Feb 1, 1994·Scandinavian Journal of Gastroenterology·L AnderssonA Nilsson
Jun 18, 2019·Biochimica Et Biophysica Acta. Biomembranes·Hyungjin KimTatsuya Murakami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.